Soluble Tumor Necrosis Factor Receptor Type I Enhances Tumor Development and Persistence in Vivo

Cellular Immunology - United States
doi 10.1006/cimm.2000.1622
Full Text
Abstract

Available in full text

Categories
Immunology
Date
Authors
Publisher

Elsevier BV

Related search

CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Levels in Depressed Patients in Estonia

Medicina
Medicine
2009English

Strategies for Inhibition of Tumor Necrosis Factor in Vivo

Trends in Microbiology
VirologyInfectious DiseasesMicrobiology
1994English

Tumor Necrosis Factor

2004English

Tumor Necrosis Factor Receptor 1 Associated Periodic Syndrome

2020English

Prostaglandin E2 Inhibits Tumor Necrosis Factor-Alpha RNA Through PKA Type I

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2008English

The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble Versus Membrane-Bound Ligand

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2012English

Tumor Necrosis Factor Receptor 2: A Potential Target for Antidepressant Drug Development

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2019English

The Tumor Necrosis Factor Receptor 2 Signal Transducers TRAF2 and C-Iap1 Are Components of the Tumor Necrosis Factor Receptor 1 Signaling Complex

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy